Abstract:BACKGROUND: Cluster of differentiation 8 (CD8 T) cells play critical roles in eradicating human immunodeficiency virus (HIV)-1 infection, but little is known about the effects of T cells expressing CD8 at low levels (CD8 low ) or high levels (CD8 high ) on HIV-1 replication inhibition after HIV-1 invasion into individual.METHODS: Nineteen patients who had been acutely infected with HIV-1 (AHI) and 20 patients with chronic infection (CHI) for ≥2 years were enrolled in this study to investigate the dynamics of the quantity, activation, and immune responses of CD3 + CD8 low T cells and their counterpart CD3 + CD8 high T cells at different stages of HIV-1 infection.RESULTS: Compared with healthy donors, CD3 + CD8 low T cells expanded in HIV-1-infected individuals at different stages of infection. As HIV-1 infection progressed, CD3 + CD8 low T cells gradually decreased. Simultaneously, CD3 + CD8 high T cells was significantly reduced in the first month of AHI and then increased gradually as HIV-1 infection progressed. The classical activation of CD3 + CD8 low T cells was highest in the first month of AHI and then reduced as HIV-1 infection progressed and entered the chronic stage. Meanwhile, activated CD38 - HLA-DR + CD8 low T cells did not increase in the first month of AHI, and the number of these cells was inversely associated with viral load ( r = -0.664, P = 0.004) but positively associated with the CD4 T-cell count ( r = 0.586, P = 0.014). Increased programmed cell death protein 1 (PD-1) abundance on CD3 + CD8 low T cells was observed from the 1st month of AHI but did not continue to be enhanced, while a significant T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (TIGIT) abundance increase was observed in the 12th month of infection. Furthermore, increased PD-1 and TIGIT abundance on CD3 + CD8 low T cells was associated with a low CD4 T-cell count (PD-1: r = -0.456, P = 0.043; TIGIT: r = -0.488, P = 0.029) in CHI. Nonetheless, the nonincrease in PD-1 expression on classically activated CD3 + CD8 low T cells was inversely associated with HIV-1 viremia in the first month of AHI ( r = -0.578, P = 0.015). Notably, in the first month of AHI, few CD3 + CD8 low T cells, but comparable amounts of CD3 + CD8 high T cells, responded to Gag peptides. Then, weaker HIV-1-specific T-cell responses were induced in CD3 + CD8 low T cells than CD3 + CD8 high T cells at the 3rd and 12th months of AHI and in CHI.CONCLUSIONS: Our findings suggest that CD3 + CD8 low T cells play an anti-HIV role in the first month of infection due to their abundance but induce a weak HIV-1-specific immune response. Subsequently, CD3 + CD8 low T-cell number decreased gradually as infection persisted, and their anti-HIV functions were inferior to those of CD3 + CD8 high T cells.

Changes to il-2, ifn- and il-6 before and after the treatment of hiv-1 infection and their correlation with cd4+t cell number

Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART

Expression changes of SAMHD1 mRNA in PBMC of HIV-1 infected patients and its correlation with level of IFN-αin plasma

Association of IFNL3/IFNL4 Polymorphisms with Efficacy of Highly Active Antiretroviral Therapy in Patients with HIV-1 Infection

IL-21 level in Chinese HIV infected individuals and its dynamics undergoing HAART

Immune reconstitution in HIV-1 infected individuals with long-term highly active antiretroviral therapy

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Clinical Observation of the Changes of Serum Helper T-Lymphocytes (TH) Cytokines in Patients with HIV-infection and Opportunistic Infection

Changing roles of CD3+CD8low T cells in combating HIV-1 infection

Evaluation of serum interleukin-18 and interleukin-10 in patients with HIV-1 and hepatitis viruses co-infected subjects]

Changes in peripheral immunocytes and cytokines in patients with HIN1 influenza A virus infection

Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression

Analysis of CD44 and CD95 Expression on CD4+ T Lymphocyte of HIV-1 Infected Subjects after Effective HAART

Analysis of the expression characteristics and clinical value of immune function indicators in patients with human immunodeficiency virus infection

Correlation of Oral Microbiota with Different Immune Responses to Antiretroviral Therapy in People Living with HIV

The Expression And Clinical Significance Of Foxp3 Mrna In Peripheral Blood Monocytes From Hiv/Aids Patients

IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection

A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients

Altered T-Cell Subsets Are Associated with Dysregulated Cytokine Secretion of CD4+ T Cells During HIV Infection

Effects of Immune 2 Granule Combined with HAART Therapy treatment on IL-2 and IL-10 mRNA level of HIV/AIDS with Incomplete Immune Recovery